Search Results 61-70 of 17585 for Menses

  1. Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    No spontaneous menses ≥ 1 year, or; No menses for < 1 year with follicle-stimulating hormone (FSH) and estradiol levels in postmenopausal range, according ...

  2. Masculinizing hormone therapy - Mayo Clinic

    Find out more about masculinizing hormonal treatment used to better align the body with a person's gender identity.

  3. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 - Mayo Clinic

    - Age 50 years or under with spontaneous menses within 12 months; or - Age greater than 50-60 years with spontaneous menses within 12 months plus follicle ...

  4. A Study Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women with Type 1 Von Willebrand Disease - Mayo Clinic

    Regular menses, at least every 21-35 days. Willingness to have blood drawn/; No prior history of an allergic reaction or anaphylaxis to rVWF or TA ...

  5. The Role that Peroral Endoscopic Myotomy (POEM) Could Play in the Treatment of Achalasia - Mayo Clinic

    The patient is at least one year postmenopausal (no menses for 12 months). The patient is using a highly effective method of contraception, if childbearing ...

  6. A Study to Evaluate the Relationship Between Vaginal and Lower Urinary Tract Microbiomes and Infection After A Hysterectomy - Mayo Clinic

    Postmenopausal females (defined by cessation of menses for one full year) · Planned surgical correction of pelvic organ prolapse with transvaginal hysterectomy ...

  7. A Study of the Long-Term Safety, Tolerability, and Effectiveness of Tesevatinib for Patients Completing 24 Months of Treatment for Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    Have had any evidence of menses in the past 12 months; Have been amenorrheic for 12 or more months, if the amenorrhea is possibly due to prior chemotherapy ...

  8. A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) - Mayo Clinic

    Age > 55 years with no menses for 12 or more months without an alternative medical cause;; Age ≤55 years with no menses for 12 or more months without an ...

  9. A Study of How Age Affects Osteoclast Inhibition and Bone Formation - Mayo Clinic

    at least 5 years since their last menses; follicle stimulating hormone (FSH) > 20 IU/L. Exclusion Criteria. Abnormality in any of the screening laboratory ...

  10. Goserelin (subcutaneous route) - Side effects & uses - Mayo Clinic

    Reducing the amount of estrogen in the body is one way of treating endometriosis and cancer of the breast, and can help thin the uterus lining before surgery.